Gordon Schanzlin New Vision Institute

What Gordon Schanzlin New Vision Institute does

Gordon Schanzlin New Vision Institute (GSNVI) is a private ophthalmology and vision correction practice headquartered at 4130 La Jolla Village Dr in San Diego, California. Founded by Dr. Michael Gordon and Dr. David J. Schanzlin, the practice has performed over 100,000 laser vision correction surgeries since inception and operates a multi-specialty clinical team of nine physicians covering LASIK, PRK, EVO ICL implantable lenses, cataract surgery with premium intraocular lenses, refractive lens exchange, presbyopia correction, dry eye management, dry AMD photobiomodulation (Valeda), and aesthetic services.

The practice is differentiated by early adoption of next-generation ophthalmic technology. GSNVI was the first practice in the U.S. to deploy both devices of Alcon's Unity Phaco cataract system (June 2025) and is among the first nationally to offer Alcon Sightmap 3D diagnostic imaging (June 2025); it was also the first San Diego provider of the RxSight Light Adjustable Lens (August 2020). The WaveLight EX500 excimer laser, Contoura Vision topography-guided LASIK, WaveLight Plus Ray-Tracing, LipiFlow, iLux, and the LumiThera Valeda Light Delivery System round out the technology stack. Clinical trial participation with Alcon and LumiThera provides preferred access to new devices.

GSNVI generates revenue primarily from one-time surgical procedures (LASIK at ~$5,200 for both eyes per national average, premium cataract surgery, RLE) plus ongoing dry eye and AMD treatment programs, aesthetic procedures (BOTOX, fillers, eyelid surgery), and general eye care services. Financing is provided through independent medical lenders, and the practice distributes services via direct consultation, a physician referral portal (refer.gwsvision.com), and a co-management network with the San Diego Eye Bank. Marketing is concentrated in San Diego County, supported by content/SEO, organic social, and Google remarketing. The practice operates as an independent physician-owned group with no disclosed institutional investors or parent entity.

Name

Gordon Schanzlin New Vision Institute

Legal name

Gordon Schanzlin New Vision Institute

Website

https://gwsvision.com

Company type

Private

Founded year

1993

Operating status

Operating

Headcount range

11–50 employees

Short description

Gordon Schanzlin New Vision Institute is a private San Diego ophthalmology practice specializing in LASIK, premium cataract surgery, refractive lens exchange, dry eye, and aesthetic eye treatments, serving adult vision-correction and cataract patients across the San Diego region.

Ownership category

akta.pro rank

Product category

Ophthalmology Services

NAICS

Offices of Optometrists (62132)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011)

akta.pro primary industry

Cornea, External Disease & Refractive Surgery (LASIK/PRK) (HLAKAKAF)

akta.pro secondary industries

Ophthalmology Surgery Centers (HLAFAIAF), Ocular Imaging & Diagnostic Testing Centers (HLAKAKAN)

Keywords

• LASIK eye surgery
• Cataract surgery
• Refractive surgery services
• Dry eye treatment
• Ophthalmology practice

Headquarters

HQ city

San Diego

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure, Supply Chain

Revenue model

1. Surgical Vision Correction Procedures: One-time surgical procedures including LASIK, PRK, EVO ICL, refractive lens exchange (RLE), and cataract surgery. Revenue generated per procedure with pricing based on technology, surgeon, prescription complexity, and medical needs. Financing options available through third-party medical lenders.
2. Cataract Surgery with IOL Implants: Surgical removal of cataracts with intraocular lens (IOL) implantation. Includes standard and premium lens options (multifocal, toric, Light Adjustable Lens). Revenue varies by lens type chosen.
3. Aesthetic and Elective Procedures: Cosmetic and elective procedures including BOTOX, Dysport, dermal fillers, eyelid surgery, facelifts, and Latisse. One-time procedures with per-treatment or per-session pricing.
4. Dry Eye and AMD Treatments: Ongoing treatment programs for dry eye syndrome (iLux, LipiFlow) and dry AMD (Valeda Light Therapy) requiring multiple sessions over time.
5. Eye Care Services: Diagnostic examinations, consultations, and ongoing eye care for conditions including keratoconus, pterygium, glaucoma, diabetic retinopathy, and presbyopia management.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels8 records

Core offering

Gordon Schanzlin New Vision Institute is a physician-owned ophthalmology practice in San Diego delivering laser vision correction (LASIK, PRK, EVO ICL), cataract surgery with premium IOLs (including RxSight Light Adjustable Lens), refractive lens exchange, presbyopia treatment, dry eye therapy, Valeda Light Therapy for dry AMD, and cosmetic/aesthetic procedures. The practice operates from an office-based surgical suite and pairs each patient with a personalized treatment plan using advanced diagnostic and surgical technologies.

Product overview

Gordon Schanzlin New Vision Institute offers a comprehensive vision correction practice centered on multiple surgical and non-surgical eye care products. The core portfolio includes laser vision correction procedures (LASIK with Contoura Vision and WaveLight Plus Ray-Tracing, PRK), implantable lens options (EVO ICL, Refractive Lens Exchange), cataract surgery with various IOLs (including the RxSight Light Adjustable Lens), and treatments for presbyopia and dry eye (iLux, LipiFlow). The practice also provides Valeda Light Therapy for dry AMD and aesthetic services (BOTOX, fillers, eyelid surgery). Advanced diagnostic and surgical technologies include Alcon Sightmap for 3D eye mapping and the Alcon Unity Phaco System for cataract surgery. With over 100,000 procedures performed, the institute serves as both a clinical practice and a site for clinical trials.

Differentiator

Problem solved

Functional benefit

Products and services

• LASIK Eye Surgery Laser vision correction procedure that reshapes the cornea under a flap using an excimer laser, offered to adults seeking to reduce or eliminate dependence on glasses or contact lenses. Includes Advanced LASIK with Contoura Vision and WaveLight Plus Ray-Tracing options.
• PRK (Photorefractive Keratectomy) Surface-based laser vision correction that reshapes the cornea without creating a corneal flap, recommended for patients with thinner corneas, active lifestyles, or military service requirements.
• EVO ICL (Implantable Collamer Lens) Reversible implantable lens placed behind the iris that corrects moderate-to-high myopia without removing corneal tissue, suited for patients with thin corneas or those seeking a non-laser vision correction option.
• Cataract Surgery Surgical removal of the clouded natural lens with replacement by an artificial intraocular lens (IOL), including advanced laser-assisted and custom cataract surgery options with premium IOL choices.
• Refractive Lens Exchange (RLE) Replacement of the eye's natural lens with an artificial intraocular lens to correct presbyopia (age-related reading vision loss) and prevent future cataracts, with multifocal and accommodating lens options.
• Presbyopia Treatment Comprehensive treatment options for age-related loss of near reading vision, including monovision LASIK, corneal inlays (KAMRA, Raindrop), and refractive lens exchange.
• Dry Eye Treatment Comprehensive dry eye diagnosis and treatment program using advanced technologies including iLux and LipiFlow thermal pulsation systems to address meibomian gland dysfunction and chronic dry eye symptoms.
• Valeda Light Therapy for Dry AMD FDA-authorized photobiomodulation therapy using specific wavelengths of therapeutic light to stimulate cellular repair at the mitochondrial level in retinal cells, for patients with dry age-related macular degeneration (AMD).
• Aesthetics Services Cosmetic and aesthetic services including BOTOX, Dysport, dermal fillers, fat injection, eyelid surgery, brow lift, facelift, LATISSE eyelash enhancement, and IPL laser skin rejuvenation delivered by oculofacial plastic specialists.

Quantifiable outcome

• Over 100,000 laser vision correction surgeries performed including LASIK, PRK, and EVO ICL
• +5 more outcomes

Named customers2 records

Segments6 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration4 records

Feature7 records

Partnerships

Six partnerships are on record, tiered flagship and core.

• Alcon (Unity Phaco System)flagshipTechnology or Integration · 23 June 2025GSNVI was the first practice in the U.S. to use both devices in Alcon's Unity Phaco system for cataract surgery. Dr. Julio Echegoyen helped test this technology through clinical trials, working directly with developers to ensure safer, more effective results. The Unity Phaco system represents the first major upgrade in cataract surgery tools in over 15 years.
• Alcon (Sightmap)flagshipTechnology or Integration · 4 June 2025GSNVI is among the first in the nation to offer Alcon Sightmap diagnostic imaging platform. Dr. Michael Gordon participated in Sightmap clinical trials. Sightmap creates detailed 3D models of the eye for personalized LASIK treatment planning, eliminating manual data entry and reducing human error.
• RxSight (Light Adjustable Lens)coreTechnology or Integration · 11 August 2020GSNVI was the first practice in San Diego to offer the RxSight Light Adjustable Lens for cataract surgery. This revolutionary IOL is the first and only lens with post-surgery prescription adjustment capability, allowing fine-tuning after healing.
• San Diego Eye BankcoreStrategic or Co-development PartnerGordon Schanzlin New Vision Institute maintains a 20+ year relationship with San Diego Eye Bank, California's largest eye bank. Dr. David Schanzlin serves as President of the Board of Directors, and Dr. Julio Echegoyen serves on the Board. The practice supports eye donation awareness and cornea transplantation services, helping restore vision for over 25,000 people. GSNVI doctors and SDEB jointly sponsor annual ophthalmology networking events.
• Alcon (WaveLight EX500)coreTechnology or IntegrationGSNVI utilizes the Alcon WaveLight EX500 excimer laser with PerfectPulse technology for LASIK procedures. The laser features advanced eye tracking with 2 millisecond latency for precision treatment.
• Lumithera (Valeda)coreTechnology or IntegrationGSNVI offers the FDA-authorized Valeda Light Delivery System for photobiomodulation treatment of dry age-related macular degeneration. Valeda is the first and only FDA-authorized device treatment with clinical evidence of improving visual function in dry AMD patients.

Scale indicators8 records

Recent moves7 records

Expansion highlights5 records

Direct peers

• NVISION Eye Centers: Multi-location U.S. ophthalmology group offering LASIK, cataract surgery with premium IOLs, and other refractive procedures. Directly comparable business model and patient mix to GSNVI, but with broader geographic reach.
• TLC Laser Eye Centers: Specialty refractive surgery chain performing LASIK, PRK, and cataract surgery across North America. Closest direct peer in terms of procedure mix and premium-IOL focus.
• LASIKPlus: Large national LASIK-focused brand with significant marketing scale. Competes with GSNVI for the same refractive-surgery patient pool, typically at lower price points.
• IQ Laser Vision: West Coast refractive surgery practice offering LASIK, PRK, ICL, and cataract procedures. Operates in overlapping California markets with similar premium-technology positioning.
• Manatee Eye Center: Multi-specialty ophthalmology practice providing cataract surgery, LASIK, and dry-eye treatments in a defined regional market. Comparable private-practice, multi-specialty refractive model.
• Eye Doctors of Washington: Multi-physician ophthalmology practice offering LASIK, cataract, glaucoma and aesthetic services. Comparable specialty mix and physician-owned model.

Broad incumbents

• Stanford Byers Eye Institute: Academic ophthalmology center delivering comprehensive eye care including refractive and cataract surgery. Larger and broader in scope, but competes for the same premium patient segment in California.
• Cleveland Clinic Cole Eye Institute: Major academic ophthalmology department performing high volumes of cataract, refractive, and retina procedures. Sets a benchmark for clinical outcomes and technology adoption relevant to specialty practices.

Others

• RxSight: Manufacturer of the Light Adjustable Lens used by GSNVI. A vendor and technology partner rather than a competitor, but an important ecosystem participant whose commercial trajectory affects GSNVI's premium-IOL offering.
• Alcon: Supplier of WaveLight EX500, Sightmap, and Unity Phaco platforms deployed by GSNVI. Strategic technology partner and ecosystem participant whose product roadmap directly shapes GSNVI's competitive positioning.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks7 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/user/GBWVisionInstitute
• Facebookfacebook.com/lasiksandiego
• Instagraminstagram.com/gwsvision
• Xx.com/gwsvi
• LinkedInlinkedin.com/company/gordon-schanzlin-new-vision-institute

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles9 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Gordon Schanzlin New Vision Institute